
The chief scientific officer at Candel Therapeutics discussed progress in investigations with CAN-3110 and CAN-2409.
The chief scientific officer at Candel Therapeutics discussed progress in investigations with CAN-3110 and CAN-2409.
The chief scientific officer at Candel Therapeutics discussed late-breaking data presented at ASGCT 2023.